2004659-84-9: Sorafenib Inhouse Impurity B

2004659-84-9: Sorafenib Inhouse Impurity B

Sorafenib Inhouse Impurity B (CAS No: 2004659-84-9) Or 4-(4-Formamidophenoxy)-N-methylpicolinamide, is an impurity of Sorafenib, Sorafenib is a potent oral multi-kinase inhibitor, which is used for cancer treatment, also used for SORA exhibits anti-angiogenic and anti-tumor activity.

Additional information on CAS 2004659-84-9

Catalogue No.

VE008167
CAS No.

2004659-84-9
Molecular Formula

C14H13N3O3
Molecular Weight

271.27 g/mol
Parent drug

Sorafenib
IUPAC Name

4-(4-Formamidophenoxy)-N-methylpicolinamide
Synonyms

N/A
References

Sci-Hub, LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products, 10.1016/j.jpba.2019.112881. (2019). Retrieved January 21, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/j.jpba.2019.112881
Status

In-stock

Other products related to sorafenib

Request a quote

2004659-84-9: Sorafenib Inhouse Impurity B

2004659-84-9: Sorafenib Inhouse Impurity B
Catalogue No.

VE008167
CAS No.

2004659-84-9
Molecular Formula

C14H13N3O3
Molecular Weight

271.27 g/mol
Parent drug

Sorafenib
IUPAC Name

4-(4-Formamidophenoxy)-N-methylpicolinamide
Synonyms

N/A
References

Sci-Hub, LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products, 10.1016/j.jpba.2019.112881. (2019). Retrieved January 21, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/j.jpba.2019.112881
Status

In-stock
ListName

Sorafenib Inhouse Impurity B
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url